ICD1865K.m

ICD1865K ;ALB/JDG - YEARLY DRG UPDATE;8/9/2010

 ;;18.0;DRG Grouper;**65**;Oct 20, 2000;Build 7

 ;

 ; Updates for DRGS 810-999

 Q

 ;

MSDRG ;;MS-DRG^MDC^TYPE^MS-DRG TITLE^WEIGHTS^GEOMETRIC MEAN LOS

 ;;810^16^MED^MAJOR HEMATOL/IMMUN DIAG EXC SICKLE CELL CRISIS & COAGUL W/O CC/MCC^0.8490^2.7

 ;;811^16^MED^RED BLOOD CELL DISORDERS W MCC^1.2556^3.7

 ;;812^16^MED^RED BLOOD CELL DISORDERS W/O MCC^0.7872^2.6

 ;;813^16^MED^COAGULATION DISORDERS^1.5841^3.6

 ;;814^16^MED^RETICULOENDOTHELIAL & IMMUNITY DISORDERS W MCC^1.6794^4.9

 ;;815^16^MED^RETICULOENDOTHELIAL & IMMUNITY DISORDERS W CC^1.0102^3.5

 ;;816^16^MED^RETICULOENDOTHELIAL & IMMUNITY DISORDERS W/O CC/MCC^0.6918^2.5

 ;;820^17^SURG^LYMPHOMA & LEUKEMIA W MAJOR O.R. PROCEDURE W MCC^5.7228^12.7

 ;;821^17^SURG^LYMPHOMA & LEUKEMIA W MAJOR O.R. PROCEDURE W CC^2.3066^5.0

 ;;822^17^SURG^LYMPHOMA & LEUKEMIA W MAJOR O.R. PROCEDURE W/O CC/MCC^1.1935^2.2

 ;;823^17^SURG^LYMPHOMA & NON-ACUTE LEUKEMIA W OTHER O.R. PROC W MCC^4.5397^11.7

 ;;824^17^SURG^LYMPHOMA & NON-ACUTE LEUKEMIA W OTHER O.R. PROC W CC^2.2603^6.2

 ;;825^17^SURG^LYMPHOMA & NON-ACUTE LEUKEMIA W OTHER O.R. PROC W/O CC/MCC^1.2712^2.7

 ;;826^17^SURG^MYELOPROLIF DISORD OR POORLY DIFF NEOPL W MAJ O.R. PROC W MCC^4.8680^10.9

 ;;827^17^SURG^MYELOPROLIF DISORD OR POORLY DIFF NEOPL W MAJ O.R. PROC W CC^2.1765^5.3

 ;;828^17^SURG^MYELOPROLIF DISORD OR POORLY DIFF NEOPL W MAJ O.R. PROC W/O CC/MCC^1.3409^2.8

 ;;829^17^SURG^MYELOPROLIF DISORD OR POORLY DIFF NEOPL W OTHER O.R. PROC W CC/MCC^3.0335^6.4

 ;;830^17^SURG^MYELOPROLIF DISORD OR POORLY DIFF NEOPL W OTHER O.R. PROC W/O CC/MCC^1.1804^2.5

 ;;834^17^MED^ACUTE LEUKEMIA W/O MAJOR O.R. PROCEDURE W MCC^5.1622^9.9

 ;;835^17^MED^ACUTE LEUKEMIA W/O MAJOR O.R. PROCEDURE W CC^2.2133^5.1

 ;;836^17^MED^ACUTE LEUKEMIA W/O MAJOR O.R. PROCEDURE W/O CC/MCC^1.0992^2.8

 ;;837^17^MED^CHEMO W ACUTE LEUKEMIA AS SDX OR W HIGH DOSE CHEMO AGENT W MCC^6.4881^16.7

 ;;838^17^MED^CHEMO W ACUTE LEUKEMIA AS SDX W CC OR HIGH DOSE CHEMO AGENT^2.7537^7.2

 ;;839^17^MED^CHEMO W ACUTE LEUKEMIA AS SDX W/O CC/MCC^1.2412^4.7

 ;;840^17^MED^LYMPHOMA & NON-ACUTE LEUKEMIA W MCC^3.0103^7.7

 ;;841^17^MED^LYMPHOMA & NON-ACUTE LEUKEMIA W CC^1.6192^4.8

 ;;842^17^MED^LYMPHOMA & NON-ACUTE LEUKEMIA W/O CC/MCC^1.0450^3.0

 ;;843^17^MED^OTHER MYELOPROLIF DIS OR POORLY DIFF NEOPL DIAG W MCC^1.8719^5.9

 ;;844^17^MED^OTHER MYELOPROLIF DIS OR POORLY DIFF NEOPL DIAG W CC^1.2216^4.3

 ;;845^17^MED^OTHER MYELOPROLIF DIS OR POORLY DIFF NEOPL DIAG W/O CC/MCC^0.8612^2.9

 ;;846^17^MED^CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W MCC^2.4374^5.7

 ;;847^17^MED^CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W CC^1.0447^2.9

 ;;848^17^MED^CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W/O CC/MCC^0.7878^2.4

 ;;849^17^MED^RADIOTHERAPY^1.3396^4.6

 ;;853^18^SURG^INFECTIOUS & PARASITIC DISEASES W O.R. PROCEDURE W MCC^5.3431^11.3

 ;;854^18^SURG^INFECTIOUS & PARASITIC DISEASES W O.R. PROCEDURE W CC^2.5583^7.3

 ;;855^18^SURG^INFECTIOUS & PARASITIC DISEASES W O.R. PROCEDURE W/O CC/MCC^1.5331^3.5

 ;;856^18^SURG^POSTOPERATIVE OR POST-TRAUMATIC INFECTIONS W O.R. PROC W MCC^4.8125^10.5

 ;;857^18^SURG^POSTOPERATIVE OR POST-TRAUMATIC INFECTIONS W O.R. PROC W CC^2.0649^5.8

 ;;858^18^SURG^POSTOPERATIVE OR POST-TRAUMATIC INFECTIONS W O.R. PROC W/O CC/MCC^1.2534^3.8

 ;;862^18^MED^POSTOPERATIVE & POST-TRAUMATIC INFECTIONS W MCC^2.0099^5.7

 ;;863^18^MED^POSTOPERATIVE & POST-TRAUMATIC INFECTIONS W/O MCC^0.9822^3.8

 ;;864^18^MED^FEVER^0.8443^2.9

 ;;865^18^MED^VIRAL ILLNESS W MCC^1.5181^4.4

 ;;866^18^MED^VIRAL ILLNESS W/O MCC^0.7594^2.8

 ;;867^18^MED^OTHER INFECTIOUS & PARASITIC DISEASES DIAGNOSES W MCC^2.5861^7.0

 ;;868^18^MED^OTHER INFECTIOUS & PARASITIC DISEASES DIAGNOSES W CC^1.0762^3.9

 ;;869^18^MED^OTHER INFECTIOUS & PARASITIC DISEASES DIAGNOSES W/O CC/MCC^0.7415^2.8

 ;;870^18^MED^SEPTICEMIA OR SEVERE SEPSIS W MV 96+ HOURS^5.8399^12.6

 ;;871^18^MED^SEPTICEMIA OR SEVERE SEPSIS W/O MV 96+ HOURS W MCC^1.8803^5.2

 ;;872^18^MED^SEPTICEMIA OR SEVERE SEPSIS W/O MV 96+ HOURS W/O MCC^1.0988^4.2

 ;;876^19^SURG^O.R. PROCEDURE W PRINCIPAL DIAGNOSES OF MENTAL ILLNESS^2.7097^7.5

 ;;880^19^MED^ACUTE ADJUSTMENT REACTION & PSYCHOSOCIAL DYSFUNCTION^0.6474^2.2

 ;;881^19^MED^DEPRESSIVE NEUROSES^0.6356^3.2

 ;;882^19^MED^NEUROSES EXCEPT DEPRESSIVE^0.6271^3.1

 ;;883^19^MED^DISORDERS OF PERSONALITY & IMPULSE CONTROL^1.3613^4.7

 ;;884^19^MED^ORGANIC DISTURBANCES & MENTAL RETARDATION^0.9850^3.9

 ;;885^19^MED^PSYCHOSES^0.9539^5.4

 ;;886^19^MED^BEHAVIORAL & DEVELOPMENTAL DISORDERS^0.7812^3.8

 ;;887^19^MED^OTHER MENTAL DISORDER DIAGNOSES^0.9473^3.1

 ;;894^20^MED^ALCOHOL/DRUG ABUSE OR DEPENDENCE, LEFT AMA^0.4278^2.1

 ;;895^20^MED^ALCOHOL/DRUG ABUSE OR DEPENDENCE W REHABILITATION THERAPY^1.0963^9.2

 ;;896^20^MED^ALCOHOL/DRUG ABUSE OR DEPENDENCE W/O REHABILITATION THERAPY W MCC^1.5271^4.8

 ;;897^20^MED^ALCOHOL/DRUG ABUSE OR DEPENDENCE W/O REHABILITATION THERAPY W/O MCC^0.6788^3.2

 ;;901^21^SURG^WOUND DEBRIDEMENTS FOR INJURIES W MCC^4.3477^9.9

 ;;902^21^SURG^WOUND DEBRIDEMENTS FOR INJURIES W CC^1.7079^5.0

 ;;903^21^SURG^WOUND DEBRIDEMENTS FOR INJURIES W/O CC/MCC^0.9890^3.0

 ;;904^21^SURG^SKIN GRAFTS FOR INJURIES W CC/MCC^2.9145^7.0

 ;;905^21^SURG^SKIN GRAFTS FOR INJURIES W/O CC/MCC^1.2630^3.4

 ;;906^21^SURG^HAND PROCEDURES FOR INJURIES^1.1596^2.4

 ;;907^21^SURG^OTHER O.R. PROCEDURES FOR INJURIES W MCC^3.8565^7.7

 ;;908^21^SURG^OTHER O.R. PROCEDURES FOR INJURIES W CC^1.9519^4.5

 ;;909^21^SURG^OTHER O.R. PROCEDURES FOR INJURIES W/O CC/MCC^1.2051^2.6

 ;;913^21^MED^TRAUMATIC INJURY W MCC^1.2273^3.8

 ;;914^21^MED^TRAUMATIC INJURY W/O MCC^0.6998^2.5

 ;;915^21^MED^ALLERGIC REACTIONS W MCC^1.5168^3.7

 ;;916^21^MED^ALLERGIC REACTIONS W/O MCC^0.5042^1.7

 ;;917^21^MED^POISONING & TOXIC EFFECTS OF DRUGS W MCC^1.4542^3.6

 ;;918^21^MED^POISONING & TOXIC EFFECTS OF DRUGS W/O MCC^0.6304^2.1

 ;;919^21^MED^COMPLICATIONS OF TREATMENT W MCC^1.6615^4.4

 ;;920^21^MED^COMPLICATIONS OF TREATMENT W CC^0.9693^3.1

 ;;921^21^MED^COMPLICATIONS OF TREATMENT W/O CC/MCC^0.6637^2.2

 ;;922^21^MED^OTHER INJURY, POISONING & TOXIC EFFECT DIAG W MCC^1.4305^3.9

 ;;923^21^MED^OTHER INJURY, POISONING & TOXIC EFFECT DIAG W/O MCC^0.6438^2.2

 ;;927^22^SURG^EXTENSIVE BURNS OR FULL THICKNESS BURNS W MV 96+ HRS W SKIN GRAFT^16.4026^22.5

 ;;928^22^SURG^FULL THICKNESS BURN W SKIN GRAFT OR INHAL INJ W CC/MCC^4.7919^11.2

 ;;929^22^SURG^FULL THICKNESS BURN W SKIN GRAFT OR INHAL INJ W/O CC/MCC^2.2420^5.2

 ;;933^22^MED^EXTENSIVE BURNS OR FULL THICKNESS BURNS W MV 96+ HRS W/O SKIN GRAFT^2.3740^2.5

 ;;934^22^MED^FULL THICKNESS BURN W/O SKIN GRFT OR INHAL INJ^1.5123^4.0

 ;;935^22^MED^NON-EXTENSIVE BURNS^1.3410^3.3

 ;;939^23^SURG^O.R. PROC W DIAGNOSES OF OTHER CONTACT W HEALTH SERVICES W MCC^2.7769^6.2

 ;;940^23^SURG^O.R. PROC W DIAGNOSES OF OTHER CONTACT W HEALTH SERVICES W CC^1.8108^3.6

 ;;941^23^SURG^O.R. PROC W DIAGNOSES OF OTHER CONTACT W HEALTH SERVICES W/O CC/MCC^1.1776^2.1

 ;;945^23^MED^REHABILITATION W CC/MCC^1.3204^8.3

 ;;946^23^MED^REHABILITATION W/O CC/MCC^1.2530^6.5

 ;;947^23^MED^SIGNS & SYMPTOMS W MCC^1.1131^3.6

 ;;948^23^MED^SIGNS & SYMPTOMS W/O MCC^0.7010^2.7

 ;;949^23^MED^AFTERCARE W CC/MCC^0.9372^2.8

 ;;950^23^MED^AFTERCARE W/O CC/MCC^0.5693^2.3

 ;;951^23^MED^OTHER FACTORS INFLUENCING HEALTH STATUS^0.8105^2.4

 ;;955^24^SURG^CRANIOTOMY FOR MULTIPLE SIGNIFICANT TRAUMA^5.4170^8.1

 ;;956^24^SURG^LIMB REATTACHMENT, HIP & FEMUR PROC FOR MULTIPLE SIGNIFICANT TRAUMA^3.6372^6.9

 ;;957^24^SURG^OTHER O.R. PROCEDURES FOR MULTIPLE SIGNIFICANT TRAUMA W MCC^6.4182^9.9

 ;;958^24^SURG^OTHER O.R. PROCEDURES FOR MULTIPLE SIGNIFICANT TRAUMA W CC^3.9004^7.2

 ;;959^24^SURG^OTHER O.R. PROCEDURES FOR MULTIPLE SIGNIFICANT TRAUMA W/O CC/MCC^2.5646^4.7

 ;;963^24^MED^OTHER MULTIPLE SIGNIFICANT TRAUMA W MCC^2.8483^5.8

 ;;964^24^MED^OTHER MULTIPLE SIGNIFICANT TRAUMA W CC^1.4975^4.4

 ;;965^24^MED^OTHER MULTIPLE SIGNIFICANT TRAUMA W/O CC/MCC^0.9600^3.0

 ;;969^25^SURG^HIV W EXTENSIVE O.R. PROCEDURE W MCC^5.4815^12.0

 ;;970^25^SURG^HIV W EXTENSIVE O.R. PROCEDURE W/O MCC^2.6631^5.5

 ;;974^25^MED^HIV W MAJOR RELATED CONDITION W MCC^2.5943^6.8

 ;;975^25^MED^HIV W MAJOR RELATED CONDITION W CC^1.3142^4.8

 ;;976^25^MED^HIV W MAJOR RELATED CONDITION W/O CC/MCC^0.8416^3.3

 ;;977^25^MED^HIV W OR W/O OTHER RELATED CONDITION^1.0517^3.5

 ;;981^99^SURG^EXTENSIVE O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS W MCC^5.0270^10.5

 ;;982^99^SURG^EXTENSIVE O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS W CC^2.8276^6.0

 ;;983^99^SURG^EXTENSIVE O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS W/O CC/MCC^1.7175^2.9

 ;;984^99^SURG^PROSTATIC O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS W MCC^3.6217^10.6

 ;;985^99^SURG^PROSTATIC O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS W CC^2.0895^6.1

 ;;986^99^SURG^PROSTATIC O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS W/O CC/MCC^1.0710^2.5

 ;;987^99^SURG^NON-EXTENSIVE O.R. PROC UNRELATED TO PRINCIPAL DIAGNOSIS W MCC^3.3374^8.6

 ;;988^99^SURG^NON-EXTENSIVE O.R. PROC UNRELATED TO PRINCIPAL DIAGNOSIS W CC^1.8141^5.0

 ;;989^99^SURG^NON-EXTENSIVE O.R. PROC UNRELATED TO PRINCIPAL DIAGNOSIS W/O CC/MCC^1.0150^2.2

 ;;998^99^**^PRINCIPAL DIAGNOSIS INVALID AS DISCHARGE DIAGNOSIS^0.0000^0.0

 ;;999^99^**^UNGROUPABLE^0.0000^0.0

 ;;EXIT

 Q

ICD1865K  ;ALB/JDG - YEARLY DRG UPDATE;8/9/2010

 +1       ;;18.0;DRG Grouper;**65**;Oct 20, 2000;Build 7

 +2       ;

 +3       ; Updates for DRGS 810-999

 +4        QUIT 

 +5       ;

MSDRG     ;;MS-DRG^MDC^TYPE^MS-DRG TITLE^WEIGHTS^GEOMETRIC MEAN LOS

 +1       ;;810^16^MED^MAJOR HEMATOL/IMMUN DIAG EXC SICKLE CELL CRISIS & COAGUL W/O CC/MCC^0.8490^2.7

 +2       ;;811^16^MED^RED BLOOD CELL DISORDERS W MCC^1.2556^3.7

 +3       ;;812^16^MED^RED BLOOD CELL DISORDERS W/O MCC^0.7872^2.6

 +4       ;;813^16^MED^COAGULATION DISORDERS^1.5841^3.6

 +5       ;;814^16^MED^RETICULOENDOTHELIAL & IMMUNITY DISORDERS W MCC^1.6794^4.9

 +6       ;;815^16^MED^RETICULOENDOTHELIAL & IMMUNITY DISORDERS W CC^1.0102^3.5

 +7       ;;816^16^MED^RETICULOENDOTHELIAL & IMMUNITY DISORDERS W/O CC/MCC^0.6918^2.5

 +8       ;;820^17^SURG^LYMPHOMA & LEUKEMIA W MAJOR O.R. PROCEDURE W MCC^5.7228^12.7

 +9       ;;821^17^SURG^LYMPHOMA & LEUKEMIA W MAJOR O.R. PROCEDURE W CC^2.3066^5.0

 +10      ;;822^17^SURG^LYMPHOMA & LEUKEMIA W MAJOR O.R. PROCEDURE W/O CC/MCC^1.1935^2.2

 +11      ;;823^17^SURG^LYMPHOMA & NON-ACUTE LEUKEMIA W OTHER O.R. PROC W MCC^4.5397^11.7

 +12      ;;824^17^SURG^LYMPHOMA & NON-ACUTE LEUKEMIA W OTHER O.R. PROC W CC^2.2603^6.2

 +13      ;;825^17^SURG^LYMPHOMA & NON-ACUTE LEUKEMIA W OTHER O.R. PROC W/O CC/MCC^1.2712^2.7

 +14      ;;826^17^SURG^MYELOPROLIF DISORD OR POORLY DIFF NEOPL W MAJ O.R. PROC W MCC^4.8680^10.9

 +15      ;;827^17^SURG^MYELOPROLIF DISORD OR POORLY DIFF NEOPL W MAJ O.R. PROC W CC^2.1765^5.3

 +16      ;;828^17^SURG^MYELOPROLIF DISORD OR POORLY DIFF NEOPL W MAJ O.R. PROC W/O CC/MCC^1.3409^2.8

 +17      ;;829^17^SURG^MYELOPROLIF DISORD OR POORLY DIFF NEOPL W OTHER O.R. PROC W CC/MCC^3.0335^6.4

 +18      ;;830^17^SURG^MYELOPROLIF DISORD OR POORLY DIFF NEOPL W OTHER O.R. PROC W/O CC/MCC^1.1804^2.5

 +19      ;;834^17^MED^ACUTE LEUKEMIA W/O MAJOR O.R. PROCEDURE W MCC^5.1622^9.9

 +20      ;;835^17^MED^ACUTE LEUKEMIA W/O MAJOR O.R. PROCEDURE W CC^2.2133^5.1

 +21      ;;836^17^MED^ACUTE LEUKEMIA W/O MAJOR O.R. PROCEDURE W/O CC/MCC^1.0992^2.8

 +22      ;;837^17^MED^CHEMO W ACUTE LEUKEMIA AS SDX OR W HIGH DOSE CHEMO AGENT W MCC^6.4881^16.7

 +23      ;;838^17^MED^CHEMO W ACUTE LEUKEMIA AS SDX W CC OR HIGH DOSE CHEMO AGENT^2.7537^7.2

 +24      ;;839^17^MED^CHEMO W ACUTE LEUKEMIA AS SDX W/O CC/MCC^1.2412^4.7

 +25      ;;840^17^MED^LYMPHOMA & NON-ACUTE LEUKEMIA W MCC^3.0103^7.7

 +26      ;;841^17^MED^LYMPHOMA & NON-ACUTE LEUKEMIA W CC^1.6192^4.8

 +27      ;;842^17^MED^LYMPHOMA & NON-ACUTE LEUKEMIA W/O CC/MCC^1.0450^3.0

 +28      ;;843^17^MED^OTHER MYELOPROLIF DIS OR POORLY DIFF NEOPL DIAG W MCC^1.8719^5.9

 +29      ;;844^17^MED^OTHER MYELOPROLIF DIS OR POORLY DIFF NEOPL DIAG W CC^1.2216^4.3

 +30      ;;845^17^MED^OTHER MYELOPROLIF DIS OR POORLY DIFF NEOPL DIAG W/O CC/MCC^0.8612^2.9

 +31      ;;846^17^MED^CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W MCC^2.4374^5.7

 +32      ;;847^17^MED^CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W CC^1.0447^2.9

 +33      ;;848^17^MED^CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W/O CC/MCC^0.7878^2.4

 +34      ;;849^17^MED^RADIOTHERAPY^1.3396^4.6

 +35      ;;853^18^SURG^INFECTIOUS & PARASITIC DISEASES W O.R. PROCEDURE W MCC^5.3431^11.3

 +36      ;;854^18^SURG^INFECTIOUS & PARASITIC DISEASES W O.R. PROCEDURE W CC^2.5583^7.3

 +37      ;;855^18^SURG^INFECTIOUS & PARASITIC DISEASES W O.R. PROCEDURE W/O CC/MCC^1.5331^3.5

 +38      ;;856^18^SURG^POSTOPERATIVE OR POST-TRAUMATIC INFECTIONS W O.R. PROC W MCC^4.8125^10.5

 +39      ;;857^18^SURG^POSTOPERATIVE OR POST-TRAUMATIC INFECTIONS W O.R. PROC W CC^2.0649^5.8

 +40      ;;858^18^SURG^POSTOPERATIVE OR POST-TRAUMATIC INFECTIONS W O.R. PROC W/O CC/MCC^1.2534^3.8

 +41      ;;862^18^MED^POSTOPERATIVE & POST-TRAUMATIC INFECTIONS W MCC^2.0099^5.7

 +42      ;;863^18^MED^POSTOPERATIVE & POST-TRAUMATIC INFECTIONS W/O MCC^0.9822^3.8

 +43      ;;864^18^MED^FEVER^0.8443^2.9

 +44      ;;865^18^MED^VIRAL ILLNESS W MCC^1.5181^4.4

 +45      ;;866^18^MED^VIRAL ILLNESS W/O MCC^0.7594^2.8

 +46      ;;867^18^MED^OTHER INFECTIOUS & PARASITIC DISEASES DIAGNOSES W MCC^2.5861^7.0

 +47      ;;868^18^MED^OTHER INFECTIOUS & PARASITIC DISEASES DIAGNOSES W CC^1.0762^3.9

 +48      ;;869^18^MED^OTHER INFECTIOUS & PARASITIC DISEASES DIAGNOSES W/O CC/MCC^0.7415^2.8

 +49      ;;870^18^MED^SEPTICEMIA OR SEVERE SEPSIS W MV 96+ HOURS^5.8399^12.6

 +50      ;;871^18^MED^SEPTICEMIA OR SEVERE SEPSIS W/O MV 96+ HOURS W MCC^1.8803^5.2

 +51      ;;872^18^MED^SEPTICEMIA OR SEVERE SEPSIS W/O MV 96+ HOURS W/O MCC^1.0988^4.2

 +52      ;;876^19^SURG^O.R. PROCEDURE W PRINCIPAL DIAGNOSES OF MENTAL ILLNESS^2.7097^7.5

 +53      ;;880^19^MED^ACUTE ADJUSTMENT REACTION & PSYCHOSOCIAL DYSFUNCTION^0.6474^2.2

 +54      ;;881^19^MED^DEPRESSIVE NEUROSES^0.6356^3.2

 +55      ;;882^19^MED^NEUROSES EXCEPT DEPRESSIVE^0.6271^3.1

 +56      ;;883^19^MED^DISORDERS OF PERSONALITY & IMPULSE CONTROL^1.3613^4.7

 +57      ;;884^19^MED^ORGANIC DISTURBANCES & MENTAL RETARDATION^0.9850^3.9

 +58      ;;885^19^MED^PSYCHOSES^0.9539^5.4

 +59      ;;886^19^MED^BEHAVIORAL & DEVELOPMENTAL DISORDERS^0.7812^3.8

 +60      ;;887^19^MED^OTHER MENTAL DISORDER DIAGNOSES^0.9473^3.1

 +61      ;;894^20^MED^ALCOHOL/DRUG ABUSE OR DEPENDENCE, LEFT AMA^0.4278^2.1

 +62      ;;895^20^MED^ALCOHOL/DRUG ABUSE OR DEPENDENCE W REHABILITATION THERAPY^1.0963^9.2

 +63      ;;896^20^MED^ALCOHOL/DRUG ABUSE OR DEPENDENCE W/O REHABILITATION THERAPY W MCC^1.5271^4.8

 +64      ;;897^20^MED^ALCOHOL/DRUG ABUSE OR DEPENDENCE W/O REHABILITATION THERAPY W/O MCC^0.6788^3.2

 +65      ;;901^21^SURG^WOUND DEBRIDEMENTS FOR INJURIES W MCC^4.3477^9.9

 +66      ;;902^21^SURG^WOUND DEBRIDEMENTS FOR INJURIES W CC^1.7079^5.0

 +67      ;;903^21^SURG^WOUND DEBRIDEMENTS FOR INJURIES W/O CC/MCC^0.9890^3.0

 +68      ;;904^21^SURG^SKIN GRAFTS FOR INJURIES W CC/MCC^2.9145^7.0

 +69      ;;905^21^SURG^SKIN GRAFTS FOR INJURIES W/O CC/MCC^1.2630^3.4

 +70      ;;906^21^SURG^HAND PROCEDURES FOR INJURIES^1.1596^2.4

 +71      ;;907^21^SURG^OTHER O.R. PROCEDURES FOR INJURIES W MCC^3.8565^7.7

 +72      ;;908^21^SURG^OTHER O.R. PROCEDURES FOR INJURIES W CC^1.9519^4.5

 +73      ;;909^21^SURG^OTHER O.R. PROCEDURES FOR INJURIES W/O CC/MCC^1.2051^2.6

 +74      ;;913^21^MED^TRAUMATIC INJURY W MCC^1.2273^3.8

 +75      ;;914^21^MED^TRAUMATIC INJURY W/O MCC^0.6998^2.5

 +76      ;;915^21^MED^ALLERGIC REACTIONS W MCC^1.5168^3.7

 +77      ;;916^21^MED^ALLERGIC REACTIONS W/O MCC^0.5042^1.7

 +78      ;;917^21^MED^POISONING & TOXIC EFFECTS OF DRUGS W MCC^1.4542^3.6

 +79      ;;918^21^MED^POISONING & TOXIC EFFECTS OF DRUGS W/O MCC^0.6304^2.1

 +80      ;;919^21^MED^COMPLICATIONS OF TREATMENT W MCC^1.6615^4.4

 +81      ;;920^21^MED^COMPLICATIONS OF TREATMENT W CC^0.9693^3.1

 +82      ;;921^21^MED^COMPLICATIONS OF TREATMENT W/O CC/MCC^0.6637^2.2

 +83      ;;922^21^MED^OTHER INJURY, POISONING & TOXIC EFFECT DIAG W MCC^1.4305^3.9

 +84      ;;923^21^MED^OTHER INJURY, POISONING & TOXIC EFFECT DIAG W/O MCC^0.6438^2.2

 +85      ;;927^22^SURG^EXTENSIVE BURNS OR FULL THICKNESS BURNS W MV 96+ HRS W SKIN GRAFT^16.4026^22.5

 +86      ;;928^22^SURG^FULL THICKNESS BURN W SKIN GRAFT OR INHAL INJ W CC/MCC^4.7919^11.2

 +87      ;;929^22^SURG^FULL THICKNESS BURN W SKIN GRAFT OR INHAL INJ W/O CC/MCC^2.2420^5.2

 +88      ;;933^22^MED^EXTENSIVE BURNS OR FULL THICKNESS BURNS W MV 96+ HRS W/O SKIN GRAFT^2.3740^2.5

 +89      ;;934^22^MED^FULL THICKNESS BURN W/O SKIN GRFT OR INHAL INJ^1.5123^4.0

 +90      ;;935^22^MED^NON-EXTENSIVE BURNS^1.3410^3.3

 +91      ;;939^23^SURG^O.R. PROC W DIAGNOSES OF OTHER CONTACT W HEALTH SERVICES W MCC^2.7769^6.2

 +92      ;;940^23^SURG^O.R. PROC W DIAGNOSES OF OTHER CONTACT W HEALTH SERVICES W CC^1.8108^3.6

 +93      ;;941^23^SURG^O.R. PROC W DIAGNOSES OF OTHER CONTACT W HEALTH SERVICES W/O CC/MCC^1.1776^2.1

 +94      ;;945^23^MED^REHABILITATION W CC/MCC^1.3204^8.3

 +95      ;;946^23^MED^REHABILITATION W/O CC/MCC^1.2530^6.5

 +96      ;;947^23^MED^SIGNS & SYMPTOMS W MCC^1.1131^3.6

 +97      ;;948^23^MED^SIGNS & SYMPTOMS W/O MCC^0.7010^2.7

 +98      ;;949^23^MED^AFTERCARE W CC/MCC^0.9372^2.8

 +99      ;;950^23^MED^AFTERCARE W/O CC/MCC^0.5693^2.3

 +100     ;;951^23^MED^OTHER FACTORS INFLUENCING HEALTH STATUS^0.8105^2.4

 +101     ;;955^24^SURG^CRANIOTOMY FOR MULTIPLE SIGNIFICANT TRAUMA^5.4170^8.1

 +102     ;;956^24^SURG^LIMB REATTACHMENT, HIP & FEMUR PROC FOR MULTIPLE SIGNIFICANT TRAUMA^3.6372^6.9

 +103     ;;957^24^SURG^OTHER O.R. PROCEDURES FOR MULTIPLE SIGNIFICANT TRAUMA W MCC^6.4182^9.9

 +104     ;;958^24^SURG^OTHER O.R. PROCEDURES FOR MULTIPLE SIGNIFICANT TRAUMA W CC^3.9004^7.2

 +105     ;;959^24^SURG^OTHER O.R. PROCEDURES FOR MULTIPLE SIGNIFICANT TRAUMA W/O CC/MCC^2.5646^4.7

 +106     ;;963^24^MED^OTHER MULTIPLE SIGNIFICANT TRAUMA W MCC^2.8483^5.8

 +107     ;;964^24^MED^OTHER MULTIPLE SIGNIFICANT TRAUMA W CC^1.4975^4.4

 +108     ;;965^24^MED^OTHER MULTIPLE SIGNIFICANT TRAUMA W/O CC/MCC^0.9600^3.0

 +109     ;;969^25^SURG^HIV W EXTENSIVE O.R. PROCEDURE W MCC^5.4815^12.0

 +110     ;;970^25^SURG^HIV W EXTENSIVE O.R. PROCEDURE W/O MCC^2.6631^5.5

 +111     ;;974^25^MED^HIV W MAJOR RELATED CONDITION W MCC^2.5943^6.8

 +112     ;;975^25^MED^HIV W MAJOR RELATED CONDITION W CC^1.3142^4.8

 +113     ;;976^25^MED^HIV W MAJOR RELATED CONDITION W/O CC/MCC^0.8416^3.3

 +114     ;;977^25^MED^HIV W OR W/O OTHER RELATED CONDITION^1.0517^3.5

 +115     ;;981^99^SURG^EXTENSIVE O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS W MCC^5.0270^10.5

 +116     ;;982^99^SURG^EXTENSIVE O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS W CC^2.8276^6.0

 +117     ;;983^99^SURG^EXTENSIVE O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS W/O CC/MCC^1.7175^2.9

 +118     ;;984^99^SURG^PROSTATIC O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS W MCC^3.6217^10.6

 +119     ;;985^99^SURG^PROSTATIC O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS W CC^2.0895^6.1

 +120     ;;986^99^SURG^PROSTATIC O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS W/O CC/MCC^1.0710^2.5

 +121     ;;987^99^SURG^NON-EXTENSIVE O.R. PROC UNRELATED TO PRINCIPAL DIAGNOSIS W MCC^3.3374^8.6

 +122     ;;988^99^SURG^NON-EXTENSIVE O.R. PROC UNRELATED TO PRINCIPAL DIAGNOSIS W CC^1.8141^5.0

 +123     ;;989^99^SURG^NON-EXTENSIVE O.R. PROC UNRELATED TO PRINCIPAL DIAGNOSIS W/O CC/MCC^1.0150^2.2

 +124     ;;998^99^**^PRINCIPAL DIAGNOSIS INVALID AS DISCHARGE DIAGNOSIS^0.0000^0.0

 +125     ;;999^99^**^UNGROUPABLE^0.0000^0.0

 +126     ;;EXIT

 +127      QUIT